U.S. flag

An official website of the United States government

GTR Home > Laboratories > Variantyx, Inc.

Variantyx, Inc.

GTR Lab ID: 506526, Last updated:2025-01-02

Personnel

  • Director: Christine Stanley, PhD, FACMG, Medical Director
    Phone: +1 617-209-2090
    Email: [email protected]
  • Joline Dalton,
    Phone: 6172092090
    Fax: United States
    Email: [email protected]
  • Shirel Weiss, PhD, VP Marketing
    Phone: United States
    Email: [email protected]
  • Allan Fisher, MD, ABMGG Board Certified, ABOG, FACMG, FACOG, Diplomate of the Amer, Medical Director
    Phone: +1 617-209-2090
    Email: [email protected]

Conditions and tests

  • Amyotrophic lateral sclerosis1 test
  • Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia1 test
  • Ataxia, spastic, childhood-onset, autosomal recessive, with optic atrophy and intellectual disability2 tests
  • Ataxia-telangiectasia syndrome1 test
  • Ataxia-telangiectasia-like disorder1 test
  • Autosomal recessive ataxia due to ubiquinone deficiency1 test
  • Autosomal recessive ataxia, Beauce type1 test
  • Autosomal recessive axonal neuropathy with neuromyotonia1 test
  • Autosomal recessive spinocerebellar ataxia 101 test
  • Autosomal recessive spinocerebellar ataxia 111 test
  • Autosomal recessive spinocerebellar ataxia 131 test
  • Autosomal recessive spinocerebellar ataxia 161 test
  • Autosomal recessive spinocerebellar ataxia 201 test
  • Azorean disease2 tests
  • Becker muscular dystrophy2 tests
  • Behavioral variant of frontotemporal dementia1 test
  • Charcot-Marie-Tooth disease1 test
  • Charlevoix-Saguenay spastic ataxia2 tests
  • Congenital myasthenic syndrome1 test
  • Congenital myopathy1 test
  • Dementia, Lewy body, susceptibility to1 test
  • Dentatorubral-pallidoluysian atrophy2 tests
  • Developmental delay1 test
  • Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing1 test
  • Disorder of endocrine system1 test
  • Distal spinal muscular atrophy1 test
  • Drug metabolism or response1 test
  • Duchenne muscular dystrophy2 tests
  • Dyssynergia2 tests
  • Dystonic disorder1 test
  • Epilepsy1 test
  • Episodic ataxia type 11 test
  • Episodic ataxia type 21 test
  • Episodic ataxia type 51 test
  • Episodic ataxia type 61 test
  • Fragile X syndrome2 tests
  • Fragile X-associated tremor/ataxia syndrome1 test
  • FRAXE1 test
  • Friedreich ataxia2 tests
  • Frontotemporal dementia2 tests
  • Frontotemporal dementia and/or amyotrophic lateral sclerosis2 tests
  • Hereditary ataxia1 test
  • Hereditary cancer5 tests
  • Hereditary cancer-predisposing syndrome2 tests
  • Hereditary cerebellar ataxia1 test
  • Hereditary dementia1 test
  • Hereditary disease22 tests
  • Hereditary liability to pressure palsies1 test
  • Hereditary motor and sensory neuropathy1 test
  • Hereditary spastic paraplegia1 test
  • Human disease1 test
  • Infantile onset spinocerebellar ataxia1 test
  • Intellectual developmental disorder with autism and dysmorphic facies1 test
  • Intellectual disability1 test
  • Intellectual disability-hypotonic facies syndrome, X-linked, 11 test
  • Kennedy disease1 test
  • Lewy body dementia1 test
  • Marinesco-Sjögren syndrome1 test
  • Mitochondrial disease4 tests
  • Movement disorder2 tests
  • Muscular dystrophy2 tests
  • Myotonic dystrophy type 21 test
  • Pontoneocerebellar hypoplasia1 test
  • Riboflavin transporter deficiency1 test
  • Solid tumor1 test
  • Spastic ataxia 41 test
  • Spastic ataxia 51 test
  • Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome1 test
  • Spinal muscular atrophy1 test
  • Spinocerebellar ataxia 431 test
  • Spinocerebellar ataxia 481 test
  • Spinocerebellar ataxia 72 tests
  • Spinocerebellar ataxia type 12 tests
  • Spinocerebellar ataxia type 102 tests
  • Spinocerebellar ataxia type 111 test
  • Spinocerebellar ataxia type 122 tests
  • Spinocerebellar ataxia type 131 test
  • Spinocerebellar ataxia type 141 test
  • Spinocerebellar ataxia type 172 tests
  • Spinocerebellar ataxia type 19/221 test
  • Spinocerebellar ataxia type 22 tests
  • Spinocerebellar ataxia type 211 test
  • Spinocerebellar ataxia type 231 test
  • Spinocerebellar ataxia type 261 test
  • Spinocerebellar ataxia type 271 test
  • Spinocerebellar ataxia type 281 test
  • Spinocerebellar ataxia type 291 test
  • Spinocerebellar ataxia type 341 test
  • Spinocerebellar ataxia type 351 test
  • Spinocerebellar ataxia type 362 tests
  • Spinocerebellar ataxia type 381 test
  • Spinocerebellar ataxia type 421 test
  • Spinocerebellar ataxia type 51 test
  • Spinocerebellar ataxia type 62 tests
  • Spinocerebellar ataxia type 82 tests
  • Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy1 test
  • Steinert myotonic dystrophy syndrome1 test
  • Walker-Warburg congenital muscular dystrophy1 test

List of services

  • Whole Exome Sequencing
  • Whole Genome Sequencing

List of certifications/licenses

Certifications

  • CLIAHelp, Number: 22D2140582, Expiration date: 2026-11-13
  • CAP, Number: 8291875, Expiration date: 2026-08-31

Licenses

  • CA - California Department of Public Health CDPH, Number: CDS00800949, Expiration date: 2025-04-08
  • DC - District of Columbia Department of Health DCDOH, Number: HFD-OS6, Expiration date: 2026-08-25
  • MA - Executive Office of Health and Human Services EOHHS, Number: 5438, Expiration date: 2026-02-12
  • MD - Maryland Department of Health and Mental Hygiene DHMH, Number: 2894, Effective date: 2018-11-14 Non-expiring
  • NY - New York State Department of Health NYSDOH, Number: 9378, Expiration date: 2025-06-30
  • PA - Pennsylvania Department of Health PADOH, Number: 36456, Expiration date: 2025-08-15
  • RI - State of Rhode Island Department of Health RIDOH, Number: LCO01241, Expiration date: 2026-12-30

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.